Compare Baker Hughes Co (BKR) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baker Hughes Co vs Moderna, Inc. — how do they compare? Baker Hughes Co trades at $64.83 (market cap $63.60B), while Moderna, Inc. trades at $60.83 (market cap $23.88B). The key difference: Baker Hughes Co is far larger — about 2.7× Moderna, Inc.'s market cap, and Baker Hughes Co pays a 1.44% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| BKR | MRNA | |
|---|---|---|
Market Cap | $63.60B | $23.88B |
Sector | Energy | Health |
52-Week High | $69.67 | $81.80 |
52-Week Low | $42.51 | $22.36 |
Enterprise Value | $64.13B | $20.03B |
Dividend Yield | 1.44% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Baker Hughes Co
Baker Hughes is a global leader in oilfield services and oilfield equipment, with particularly strong presences in the artificial lift, specialty chemicals, and completions markets. The other half of its business focuses on industrial power generation, process solutions, and industrial asset management, with high exposure to the liquid natural gas market specifically, as well as broader industrials end markets.
Read more on BKR →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
